SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000165
Filing Date
2024-10-31
Accepted
2024-10-31 06:21:17
Documents
3
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 6-K form6k-1_103124.htm 6-K 820393
2 EX-99.1 exhibit991_103124.htm EX-99.1 796628
3 GRAPHIC image.jpg GRAPHIC 8056
  Complete submission text file 0001395064-24-000165.txt   1629260
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 241412280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)